Loughborough, United Kingdom — Former IBF and WBA World Super Lightweight champion, Amir Khan has received a two-year ban from all sports by the UK Anti-Doping (UKAD) over a failed drug test.
Amir Khan (34-6, 21KOs) failed a drug test following his fight with long-time rival Kell Brook in February 2022. Khan lost the match to Brook (40-3, 28KOs), who dominated the fight before recording a sixth-round stoppage in Manchester.
Khan who has since retired from boxing after the clash alleged that it was never his intention to ingest the drug but accepted the decision and punishment in good faith.
"Professional boxer and Olympic medallist Amir Khan has been banned from all sport for two years following Anti-Doping Rule Violations (ADRVs) for the presence and use of a Prohibited Substance," the UKAD said in a statement.
"On 19 February 2022, UK Anti-Doping (UKAD) collected an In-Competition urine Sample from Mr. Khan after his fight against Kell Brook at the Manchester Arena. Mr Khan's Sample returned an Adverse Analytical Finding (AAF) for ostarine. Ostarine is a selective androgen receptor modulator (SARM). The substance is listed on the World Anti-Doping Agency's (WADA) 2022 Prohibited List as an anabolic agent and is prohibited in sport at all times."
"UKAD notified Mr. Khan of the AAF on 6 April 2022 and that he may have committed ADRVs under the 2021 UK Anti-Doping Rules (ADR). UKAD issued him with a Provisional Suspension from all Code-compliant sport on the same date."
Sakyi Kwame Cornelius is a writer and boxing analyst for AceTVBoxing.com. He can be reached on Twitter @CorneliusSakyi or via email: sakyicornelius1@gmail.com.
Be the First to Comment